https://orcid.org/0000-0002-4381-6718
References
- Conforti C, Giuffrida R, Dianzani C, et al. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020:e13298.
- Megna M, Ruggiero A, Marasca C, et al. Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears. J Dermatolog Treat. 2020.
- Bardazzi F, Loi C, Sacchelli L, et al. Biologic therapy for psoriasis during the COVID-19 outbreak is not a choice. J Dermatolog Treat. 2020;31:320–321.
- SIDeMaST, Infezione da coronavirus: vademecum per i pazienti affetti da psoriasi cutanea e/o artropatia psoriasica, 25 febbraio 2020 [cited 2020 Mar 29]. Available from: https://www.sidemast.org/blog/coronavirus/
- Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–442.